Brazilian guidelines for community-acquired pneumonia in immunocompetent adults - 2009.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Jornal Brasileiro de Pneumologia

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 19618038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early goal-directed therapy in the treatment of severe sepsis and septic shock.

  2018cited by this paper
• Markers of treatment failure in hospitalised community acquired pneumonia

  2009cited by this paper
• Antibiotic timing and errors in diagnosing pneumonia.

  2008cited by this paper
• Hydrocortisone therapy for patients with septic shock.

  2008cited by this paper
• Markers of treatment failure in hospitalised community acquired pneumonia

  2008cited by this paper
• Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia.

  2008cited by this paper
• C-reactive protein is an independent predictor of severity in community-acquired pneumonia.

  2008cited by this paper
• Fluid therapy in resuscitated sepsis: less is more.

  2008cited by this paper
• The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study.

  2008cited by this paper
• Treatment and Outcomes for Patients With Bacteremic Pneumococcal Pneumonia

  2008cited by this paper
• Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

  2008cited by this paper
• Biomarkers in the diagnosis of pneumonia in the critically ill: don't shoot the piano player

  2008cited by this paper
• Evaluation of different nucleic acid amplification techniques for the detection of M. pneumoniae, C. pneumoniae and Legionella spp. in respiratory specimens from patients with community-acquired pneumonia.

  2008cited by this paper
• Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.

  2008cited by this paper
• Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock*

  2007cited by this paper
• [Predictive value of history and physical examination for the diagnosis of community-acquired pneumonia in adults: a literature review].

  2007cited by this paper
• Effects of systemic steroids in patients with severe community-acquired pneumonia

  2007cited by this paper
• Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis.

  2007cited by this paper
• Recent Advances in Community-Acquired Pneumonia

  2007cited by this paper
• Simple modification of CURB-65 better identifies patients including the elderly with severe CAP.

  2007cited by this paper
• [Predictive value of history and physical examination for the diagnosis of community-acquired pneumonia in adults: a literature review].

  2007influential reference
• Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators

  2007cited by this paper
• The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis

  2007cited by this paper
• Sensitivity of Legionella pneumophila DNA detection in serum samples in relation to disease severity.

  2007cited by this paper
• Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.

  2007cited by this paper
• The CURB 65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia

  2007cited by this paper
• Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.

  2007cited by this paper
• Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia

  2007cited by this paper
• Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores.

  2007cited by this paper
• Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study

  2007cited by this paper
• Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia

  2007cited by this paper
• Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia.

  2007cited by this paper
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

  2007cited by this paper
• A worldwide perspective of atypical pathogens in community-acquired pneumonia.

  2007cited by this paper
• Treatment failure in community-acquired pneumonia.

  2007cited by this paper
• Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia*

  2007cited by this paper
• The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia

  2006cited by this paper
• Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage.

  2006cited by this paper
• Assessment of Analysis of Urinary Pneumococcal Antigen by Immunochromatography for Etiologic Diagnosis of Community-Acquired Pneumonia in Adults

  2006cited by this paper
• Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.

  2006cited by this paper
• A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia

  2006cited by this paper
• Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts.

  2006cited by this paper
• Management of sepsis.

  2006cited by this paper
• Optimal therapy for severe pneumococcal community-acquired pneumonia

  2006cited by this paper
• Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia

  2006cited by this paper
• Validation of a predictive rule for the management of community-acquired pneumonia

  2006cited by this paper
• Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.

  2006cited by this paper
• Etiologic Diagnosis of Adult Bacterial Pneumonia by Culture and PCR Applied to Respiratory Tract Samples

  2006cited by this paper
• Nonresolving pneumonia.

  2005cited by this paper
• Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.

  2005cited by this paper
• Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review

  2005cited by this paper
• Administration of first hospital antibiotics for community-acquired pneumonia: does timeliness affect outcomes?

  2005cited by this paper
• Detection of Streptococcus pneumoniae Antigen in Bronchoalveolar Lavage Fluid Samples by a Rapid Immunochromatographic Membrane Assay

  2005cited by this paper
• Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

  2005cited by this paper
• Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*

  2005cited by this paper
• Novel, Single-Dose Microsphere Formulation of Azithromycin versus 7-Day Levofloxacin Therapy for Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults

  2005cited by this paper
• Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study

  2005cited by this paper
• Clinical inquiries. Is sputum evaluation useful for patients with community-acquired pneumonia?

  2005cited by this paper
• Radiology of community-acquired pneumonia.

  2005cited by this paper
• Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.

  2005cited by this paper
• Development and Evaluation of Chlamylege, a New Commercial Test Allowing Simultaneous Detection and Identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in Clinical Respiratory Specimens by Multiplex PCR

  2005cited by this paper
• Epidemiología de la neumonía del adulto adquirida en la comunidad

  2005cited by this paper
• Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.

  2005cited by this paper
• Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials.

  2005cited by this paper
• Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study.

  2005cited by this paper
• [Trends in morbidity for respiratory diseases among hospitalized patients in the city of São Paulo].

  2005cited by this paper
• Predicting bacteremia in patients with community-acquired pneumonia.

  2004cited by this paper
• Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.

  2004cited by this paper
• Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome

  2004cited by this paper
• Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement.

  2004cited by this paper
• In vitro activity of ertapenem against selected respiratory pathogens.

  2004cited by this paper
• Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor

  2004cited by this paper
• Diagnostic test for etiologic agents of community-acquired pneumonia

  2004cited by this paper
• Radiology of bacterial pneumonia.

  2004cited by this paper
• Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia.

  2004cited by this paper
• Interlaboratory Reliability of Microimmunofluorescence Test for Measurement of Chlamydia pneumoniae-Specific Immunoglobulin A and G Antibody Titers

  2004cited by this paper
• Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.

  2004cited by this paper
• Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.

  2004cited by this paper
• Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia.

  2004cited by this paper
• II Consenso Brasileiro de Tuberculose: Diretrizes Brasileiras para Tuberculose 2004

  2004cited by this paper
• Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.

  2004cited by this paper
• Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia.

  2003cited by this paper
• Is the lateral decubitus radiograph necessary for the management of a parapneumonic pleural effusion?

  2003cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

  2003cited by this paper
• Diagnosis of Legionella infection.

  2003cited by this paper
• [Diagnostic value of quantitative cultures of endotracheal aspirate in ventilator-associated pneumonia: a multicenter study].

  2003cited by this paper
• Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.

  2003cited by this paper
• Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment.

  2003cited by this paper
• Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

  2003cited by this paper
• Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults

  2003cited by this paper
• Molecular Diagnosis of Mycoplasma pneumoniae Respiratory Tract Infections

  2003cited by this paper
• Legionella spp.: community acquired and nosocomial infections

  2003cited by this paper
• High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.

  2003cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

  2002cited by this paper
• Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization.

  2002cited by this paper
• DIAGNOSIS OF LEGIONELLA INFECTION

  2002cited by this paper
• Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids.

  2002cited by this paper
• Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions.

  2002cited by this paper
• Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis.

  2002cited by this paper
• A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.

  2002cited by this paper

• Brazilian guide for the diagnosis of severe community-acquired pneumonia and hospital-acquired pneumonia

  2025cites this paper
• Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future

  2025cites this paper
• Investigation of etiology of community-acquired pneumonia in hospitalized patients in a tertiary hospital of São Paulo City, Brazil

  2023cites this paper
• Epidemiological profile of hospital admissions for pneumonia in Bahia, between 2015 and 2019 Perfil epidemiológico das internações hospitalares por pneumonia na Bahia, entre 2015 e 2019

  2022cites this paper
• Charlson Comorbidity Index and other predictors of in-hospital mortality among adults with community-acquired pneumonia

  2021cites this paper
• Multisystem inflammatory syndrome in children: a cross-sectional study of cases and factors associated with deaths during the COVID-19 pandemic in Brazil, 2020.

  2021cites this paper
• Síndrome inflamatória multissistêmica pediátrica: estudo seccional dos casos e fatores associados aos óbitos durante a pandemia de COVID-19 no Brasil, 2020

  2021cites this paper
• Consideration of antimicrobial resistance and contextual factors in infectious disease guidelines: a systematic survey

  2021cites this paper
• Developing the Pneumonia-Optimized Ratio for Community-acquired pneumonia: An easy, inexpensive and accurate prognostic biomarker

  2021cites this paper
• Clinical practice guidelines for the management of community‐acquired pneumonia: A critical appraisal using the AGREE II instrument

  2020cites this paper
• Derivation and validation of a novel severity scoring system for pneumonia at ICU admission.

  2020cites this paper
• Development and Implementation of a Clinical Pathway to Reduce Inappropriate Admissions Among Patients with Community-Acquired Pneumonia in a Private Health System in Brazil: An Observational Cohort Study and a Promising Tool for Efficiency Improvement

  2019cites this paper
• Fatores associados à vacinação anti-influenza e anti-pneumocócica em idosos

  2019cites this paper
• Factors associated with mortality in severe community‐acquired pneumonia: A multicenter cohort study

  2019cites this paper
• Profile and management of community acquired pneumonia in a tertiary care hospital in Karachi

  2018cites this paper
• 2018 recommendations for the management of community acquired pneumonia

  2018cites this paper
• Post-discharge mortality in patients with traumatic spinal cord injury in a Brazilian hospital: a retrospective cohort

  2018cites this paper
• Characterisation of Streptococcus pneumoniae isolates from invasive disease in adults following the introduction of PCV10 in Brazil

  2018cites this paper
• Getting to know our pneumococcus

  2018cites this paper
• Pneumonia mortality trends in all Brazilian geographical regions between 1996 and 2012

  2017cites this paper
• Pneumonia treatment by photodynamic therapy with extracorporeal illumination ‐ an experimental model

  2017cites this paper
• Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients

  2017cites this paper
• Community-acquired pneumonia in Malawian adults: Aetiology and predictors of mortality.

  2017cites this paper
• Community-Acquired Pneumonia in Latin America

  2016cites this paper
• Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study

  2015cites this paper
• IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients

  2015cites this paper
• Management of severe community-acquired pneumonia in Brazil: a secondary analysis of an international survey

  2015cites this paper
• Vaccination in the prevention of infectious respiratory diseases in adults.

  2014cites this paper
• Surveillance cultures in healthcare-associated pneumonia: sense or nonsense?

  2014cites this paper
• Guidelines for the treatment of pneumonia and urinary tract infections: evaluation of methodological quality using the Appraisal of Guidelines, Research and Evaluation II instrument.

  2013cites this paper
• Community-acquired pneumonia at the Hospital de Clínicas de Porto Alegre: evaluation of a care protocol

  2013cites this paper
• Patients hospitalized for community-acquired pneumonia present reduced functional performance.

  2013cites this paper
• Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia.

  2013cites this paper
• Viral–bacterial interactions–therapeutic implications

  2013cites this paper
• Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia

  2013cites this paper
• Community-acquired pneumonia: identification and evaluation of nonresponders

  2013cites this paper
• Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza.

  2012cites this paper
• Adherence to guidelines and its impact on outcomes in patients hospitalized with community-acquired pneumonia at a university hospital.

  2012influential citation
• Pneumonia hospitalization in Brazil from 2003 to 2007.

  2012cites this paper
• Impact of bacteremia in a cohort of patients with pneumococcal pneumonia.

  2012cites this paper
• Community-Acquired Pneumonia Guidelines: A Global Perspective

  2012cites this paper
• Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin.

  2012cites this paper
• Periodontal infections and community-acquired pneumonia: a case–control study

  2012cites this paper
• Impact of macrolide therapy on mortality of HIV-infected patients with community-acquired pneumonia in a tertiary teaching hospital.

  2011cites this paper
• Clinical, epidemiological, and etiological profile of inpatients with community-acquired pneumonia at a general hospital in the Sumaré microregion of Brazil.

  2011cites this paper
• Implementation of community-acquired pneumonia guidelines at a public hospital in Brazil.

  2011influential citation
• Tratamiento de las enfermedades infecciosas

  2011cites this paper
• Caracterización de la neumonía adquirida fuera del hospital

  2011cites this paper